86 results on '"VISCERAL leishmaniasis"'
Search Results
2. Activation of TLR-pathway to induce host Th1 immune response against visceral leishmaniasis: Involvement of galactosylated-flavonoids
- Author
-
Supratim Pradhan, Snehlata, Debolina Manna, Subir Karmakar, Manoj Kumar Singh, Arijit Bhattacharya, Budhaditya Mukherjee, and Joydeep Paul
- Subjects
Antileishmanial ,TLR-4 ,Galactosylated-Flavonoids ,Reactive oxygen species ,Th1 response ,Visceral leishmaniasis ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Immunotherapeutic strategies against visceral leishmaniasis (VL) are pertinent because of the emergence of resistance against existing chemotherapy, coupled with their toxicity and high costs. Various bioactive components with potential immunomodulatory activity, such as alkaloids, terpenes, saponins, flavonoids obtained primarily from medicinal plants, have been screened against different disease models. Reports suggested that glycans containing terminal β-galactose can skew host immune response towards Th1 by engaging TLRs. In this study, two synthesized terminal galactose-containing flavones, Quercetin 3-d-galactoside (Q-gal) and Kaempferol 3-O-d-galactoside (K-gal), are profiled in terms of inducing host protective Th1 response in both in vitro & in vivo animal models of experimental VL individually against antimony-resistant & antimony-susceptible Leishmania donovani. Further, we explored that both Q-gal and K-gal induce TLR4 mediated Th1 response to encounter VL. Molecular docking analysis also suggested strong interaction with TLR4 for both the galactosides, with a slightly better binding potential towards Q-gal. Treatment with both Q-gal and K-gal showed significant antileishmanial efficacy. Each considerably diminished the liver and splenic parasite burden 60 days after post-infection (>90% in AG83 infected mice and >87% in GE1F8R infected mice) when administered at a 5 mg/kg/day body-weight dose for ten consecutive days. However, the treatments failed to clear the parasites in the TLR4 deficient C3H/HeJ mice. Treatment with these compounds favors the elevation of TLR4 dependent host protective Th1 cytokines and suppression of disease-promoting IL-10. Q-gal and K-gal also triggered sufficient ROS generation in macrophages to kill intracellular parasites directly.
- Published
- 2022
- Full Text
- View/download PDF
3. In vitro and in vivo therapeutic antileishmanial potential of ellagic acid against Leishmania donovani in murine model.
- Author
-
Keshav, Poonam, Goyal, Deepak Kumar, and Kaur, Sukhbir
- Subjects
ELLAGIC acid ,LEISHMANIA donovani ,VISCERAL leishmaniasis ,PARASITIC diseases ,IMMUNE response ,FEVER - Abstract
Parasite of genus Leishmania viz. L. donovani and L. infantum cause visceral leishmaniasis (VL) or Kala-azar, systemic disease with significant enlargement of the liver and spleen, weight loss, anemia, fever and immunosuppression. The silent expansion of vectors, reservoir hosts and resistant strains is also of great concern in VL control. Considering all these issues, the present study focused on in vitro and in vivo antileishmanial screening of ellagic acid (EA) against L. donovani. The in vitro study was performed against the protozoan parasite L. donovani and a 50% inhibitory concentration was calculated. The DNA arrest in the sub-G0/G1 phase of the cell cycle was studied. In vivo studies included the assessment of parasite burden and immunomodulation in response to treatment of ellagic acid in BALB/c mice. The levels of Th1 and Th2 cytokines and isotype antibodies were assessed in different groups of mice. EA showed in vitro parasiticidal activity with IC
50 18.55 µg/mL and thwarted cell-cycle progression at the sub-G0/G1 phase. Administration of ellagic acid to the BALB/c mice reported diminution of splenic and hepatic parasite burden coupled with an expansion of CD4+ and CD8+ T lymphocytes. EA further potentiated a protective immune response with augmentation of Th1 type immune response evidenced by elevation of serum IgG2a levels and DTH response. EA was reported to be safe and non-toxic to the THP-1 cell line as well as to the liver and kidneys of mice. These findings endorse the therapeutic potential of EA with significant immunomodulation and can serve as a promising agent against this debilitating parasitic disease. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
4. Efficacy of Desmodium gangeticum extract and its fractions against experimental visceral leishmaniasis
- Author
-
Singh, Nasib, Mishra, Pushpesh Kumar, Kapil, Aruna, Arya, Kamal Ram, Maurya, Rakesh, and Dube, Anuradha
- Subjects
- *
DESMODIUM , *VISCERAL leishmaniasis , *LEISHMANIASIS , *PROTOZOAN diseases - Abstract
Abstract: Crude ethanolic extract of Indian medicinal plant, Desmodium gangeticum (A001) and its three fractions—hexane (F002), n-butanol (F003) and aqueous (F004) were evaluated chemoprophylactically and chemotherapeutically against experimental visceral leishmaniasis in hamsters. Ethanolic extract showed 41.2±5.3% inhibition of parasite multiplication when administered at a dose of 250mg/kg×2 on day −7 and +7 of Leishmania donovani challenge. Its n-butanol fraction exhibited better efficacy than the ethanolic extract to the tune of 66.7±6.1% inhibition when administered at similar dose schedule. But the other two fractions failed to exert any action prophylactically. F003 also imparted significant (P <0.001) non-specific resistance to peritoneal macrophages against Leishmania infection. F003 also showed moderate antileishmanial activity when tested against established infection of Leishmania donovani in hamsters but the rest three fractions failed to show any significant inhibition of parasite multiplication. These findings revealed that this plant has potential prophylactic and therapeutic efficacy against Leishmania infection and warrants detailed investigations on its possible immunopotentiatory actions. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
5. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies
- Author
-
Mahe Talat, Shyam Sundar, Shyam Lal Mudavath, O.N. Srivastava, and Madhukar Rai
- Subjects
Male ,animal diseases ,efficacy ,Molecular Conformation ,antileishmanial ,Pharmaceutical Science ,02 engineering and technology ,Pharmacology ,01 natural sciences ,Mice ,Parasitic Sensitivity Tests ,Amphotericin B ,Spectroscopy, Fourier Transform Infrared ,Drug Discovery ,Amines ,Cytotoxicity ,Original Research ,021001 nanoscience & nanotechnology ,3. Good health ,Biochemistry ,Raman spectroscopy ,Leishmaniasis, Visceral ,cytotoxicity ,Graphite ,0210 nano-technology ,medicine.drug ,Antiprotozoal Agents ,Leishmania donovani ,macrophage ,Biology ,010402 general chemistry ,Cell Line ,In vivo ,parasitic diseases ,medicine ,Animals ,Amastigote ,Drug Design, Development and Therapy ,Mesocricetus ,urogenital system ,technology, industry, and agriculture ,medicine.disease ,biology.organism_classification ,bacterial infections and mycoses ,amastigote ,In vitro ,0104 chemical sciences ,Visceral leishmaniasis ,Conjugate - Abstract
Shyam Lal Mudavath,1 Mahe Talat,2 Madhukar Rai,1 Onkar Nath Srivastava,2 Shyam Sundar1 1Infectious Disease Research Laboratory, Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India; 2Nanoscience Unit, Department of Physics, Banaras Hindu University, Varanasi, India Abstract: Amphotericin B (AmB) has been the first-line treatment for visceral leishmaniasis (VL), a neglected protozoan disease, especially in regions like Bihar, India, where resistance to antimonials is widespread. However, adverse drug reactions are a major limiting factor. We evaluated a novel formulation of AmB conjugated to amine-modified graphene (f-Gr) for safety and efficacy over conventional AmB. The f-Gr was prepared in a gentle one-step process of noncovalent (amine) functionalization with the help of amino acid L-cysteine. This f-Gr was further conjugated to AmB by peptide bond. The conjugate (f-Gr-AmB) was characterized by Raman spectroscopy, Fourier transform infrared spectroscopy, scanning electron microscopy, and transmission electron microscopy. f-Gr-AmB was found to exhibit lesser cytotoxicity toward J774A.1 cells than AmB, and did not induce any hepatic or renal toxicity in Swiss albino mice. In vitro antileishmanial assay in J774A.1 cells showed significantly enhanced efficacy of f-Gr-AmB over AmB. Furthermore, percentage inhibition of amastigote replication in a hamster model of VL was significantly higher in the f-Gr-AmB treated group (87.8%) compared to the AmB group (70.4%). These results suggest that f-Gr-AmB could be a safe and effective alternative to conventional AmB in the treatment of VL. Keywords: antileishmanial, efficacy, cytotoxicity, macrophage, Raman spectroscopy, amastigote
- Published
- 2014
6. Efficacy of artemisinin in experimental visceral leishmaniasis
- Author
-
Sen, Rupashree, Ganguly, Sudipto, Saha, Piu, and Chatterjee, Mitali
- Subjects
- *
DRUG efficacy , *ARTEMISININ , *THERAPEUTIC use of antimony , *VISCERAL leishmaniasis , *ANTIMALARIALS , *MACROPHAGES , *MESSENGER RNA , *LEISHMANIA , *NITRIC-oxide synthases , *THERAPEUTICS - Abstract
Abstract: Visceral leishmaniasis (VL), caused by the protozoan Leishmania sp., affects 500000 people annually, with the Indian subcontinent contributing a significant proportion of these cases. Emerging refractoriness to conventional antimony therapy has emphasised the need for safer yet effective antileishmanial drugs. Artemisinin, a widely used antimalarial, demonstrated anti-promastigote activity and the 50% inhibitory concentration (IC50) ranged from 100μM to 120μM irrespective of Leishmania species studied. Leishmania donovani-infected macrophages demonstrated decreased production of nitrite as well as mRNA expression of inducible nitric oxide synthase, which was normalised by artemisinin, indicating that it exerted both a direct parasiticidal activity as well as inducing a host protective response. Furthermore, in a BALB/c model of VL, orally administered artemisinin (10mg/kg and 25mg/kg body weight) effectively reduced both splenic weight and parasite burden, which was accompanied by a restoration of Th1 cytokines (interferon-gamma and interleukin-2). Taken together, these findings have delineated the therapeutic potential of artemisinin in experimental VL. [Copyright &y& Elsevier]
- Published
- 2010
- Full Text
- View/download PDF
7. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
- Author
-
Sachdeva, Heena, Sehgal, Rakesh, and Kaur, Sukhbir
- Subjects
- *
IMMUNOREGULATION , *CISPLATIN , *COMBINATION drug therapy , *VISCERAL leishmaniasis , *MOUSE diseases , *DRUG administration , *NEPHROTOXICOLOGY , *HEPATOTOXICOLOGY - Abstract
Highlights: [•] Administration of cisplatin in L. donovani infected BALB/c mice resulted in decreased parasite load. [•] Cisplatin administration was associated with hepatotoxicity and nephrotoxicity. [•] Oral treatment of T. cordifolia along with cisplatin ameliorated the cisplatin induced toxicity. [•] Combination treatment resulted in the generation of protective Th1 type of immune responses. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
8. Recent Advances in the Chemotherapy of Visceral Leishmaniasis
- Author
-
Prajapati, Vijay Kumar, Pandey, Rajan Kumar, and Grover, Abhinav, editor
- Published
- 2017
- Full Text
- View/download PDF
9. Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo.
- Author
-
Chouhan, Garima, Islamuddin, Mohammad, Want, Muzamil Y., Abdin, Malik Z., Ozbak, Hani A., Hemeg, Hassan A., Sahal, Dinkar, and Afrin, Farhat
- Subjects
- *
NEEM , *VISCERAL leishmaniasis , *PROMASTIGOTE , *GAS chromatography , *MACROPHAGES , *APOPTOSIS , *METABOLITES - Abstract
Background: Exploration of immunomodulatory antileishmanials of plant origin is now being strongly recommended to overcome the immune suppression evident during visceral leishmaniasis (VL) and high cost and toxicity associated with conventional chemotherapeutics. In accordance, we assessed the in vitro and in vivo antileishmanial and immunomodulatory potential of ethanolic fractions of Azadirachta indica leaves (ALE) and seeds (ASE). Methods: A. indica fractions were prepared by sequential extraction of the powdered plant parts in hexane, ethanol and water. Erythrosin B staining was employed to appraise the anti-promastigote potential of ALE and ASE. Cytostatic or cytocidal mode of action was ascertained and alterations in parasite morphology were depicted under oil immersion light microscopy. Study of apoptotic correlates was performed to deduce the mechanism of induced cell death and anti-amastigote potential was assessed in Leishmania parasitized RAW 264.7 macrophages. In vivo antileishmanial effectiveness was evaluated in L. donovani infected BALB/c mice, accompanied by investigation of immunomodulatory potential of ALE and ASE. Adverse toxicity of the bioactive fractions against RAW macrophages was studied by MTT assay. In vivo side effects on the liver and kidney functions were also determined. Plant secondary metabolites present in ALE and ASE were analysed by Gas chromatography-mass spectrometry (GC-MS). Results: ALE and ASE (500 μg ml1) exhibited leishmanicidal activity in a time- and dose-dependent manner (IC50 34 and 77.66 μg ml-1, respectively) with alterations in promastigote morphology and induction of apoptosis. ALE and ASE exerted appreciable anti-amastigote potency (IC50 17.66 and 24.66 μg ml-1, respectively) that was coupled with profound in vivo therapeutic efficacy (87.76% and 85.54% protection in liver and 85.55% and 83.62% in spleen, respectively). ALE exhibited minimal toxicity with selectivity index of 26.10 whereas ASE was observed to be non-toxic. The bioactive fractions revealed no hepato- and nephro-toxicity. ALE and ASE potentiated Th1-biased cell-mediated immunity along with upregulation of INF-γ, TNF-α and IL-2 and decline in IL-4 and IL-10 levels. GC-MS analysis revealed several compounds that may have contributed to the observed antileishmanial effect. Conclusion: Dual antileishmanial and immunostimulatory efficacy exhibited by the bioactive fractions merits their use alone or as adjunct therapy for VL. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo
- Author
-
Garima Chouhan, Mohammad Islamuddin, Muzamil Y Want, Malik Z Abdin, Hani A Ozbak, Hassan A Hemeg, Dinkar Sahal, and Farhat Afrin
- Subjects
Visceral Leishmaniasis ,Leishmania donovani ,Apoptosis ,Immunomodulatory ,Antileishmanial ,Immunopotentiating ,Infectious and parasitic diseases ,RC109-216 - Abstract
Abstract Background Exploration of immunomodulatory antileishmanials of plant origin is now being strongly recommended to overcome the immune suppression evident during visceral leishmaniasis (VL) and high cost and toxicity associated with conventional chemotherapeutics. In accordance, we assessed the in vitro and in vivo antileishmanial and immunomodulatory potential of ethanolic fractions of Azadirachta indica leaves (ALE) and seeds (ASE). Methods A. indica fractions were prepared by sequential extraction of the powdered plant parts in hexane, ethanol and water. Erythrosin B staining was employed to appraise the anti-promastigote potential of ALE and ASE. Cytostatic or cytocidal mode of action was ascertained and alterations in parasite morphology were depicted under oil immersion light microscopy. Study of apoptotic correlates was performed to deduce the mechanism of induced cell death and anti-amastigote potential was assessed in Leishmania parasitized RAW 264.7 macrophages. In vivo antileishmanial effectiveness was evaluated in L. donovani infected BALB/c mice, accompanied by investigation of immunomodulatory potential of ALE and ASE. Adverse toxicity of the bioactive fractions against RAW macrophages was studied by MTT assay. In vivo side effects on the liver and kidney functions were also determined. Plant secondary metabolites present in ALE and ASE were analysed by Gas chromatography–mass spectrometry (GC-MS). Results ALE and ASE (500 μg ml−1) exhibited leishmanicidal activity in a time- and dose-dependent manner (IC50 34 and 77.66 μg ml−1, respectively) with alterations in promastigote morphology and induction of apoptosis. ALE and ASE exerted appreciable anti-amastigote potency (IC50 17.66 and 24.66 μg ml−1, respectively) that was coupled with profound in vivo therapeutic efficacy (87.76% and 85.54% protection in liver and 85.55% and 83.62% in spleen, respectively). ALE exhibited minimal toxicity with selectivity index of 26.10 whereas ASE was observed to be non-toxic. The bioactive fractions revealed no hepato- and nephro-toxicity. ALE and ASE potentiated Th1-biased cell-mediated immunity along with upregulation of INF-γ, TNF-α and IL-2 and decline in IL-4 and IL-10 levels. GC-MS analysis revealed several compounds that may have contributed to the observed antileishmanial effect. Conclusion Dual antileishmanial and immunostimulatory efficacy exhibited by the bioactive fractions merits their use alone or as adjunct therapy for VL.
- Published
- 2015
- Full Text
- View/download PDF
11. Leishmanicidal Activity of Piper nigrum Bioactive Fractions is Interceded via Apoptosis In Vitro and Substantiated by Th1 Immunostimulatory Potential In Vivo.
- Author
-
Chouhan, Garima, Islamuddin, Mohammad, Want, Muzamil Y., Ozbak, Hani A., Hemeg, Hassan A., Sahal, Dinkar, and Afrin, Farhat
- Subjects
BLACK pepper (Plant) ,VISCERAL leishmaniasis ,PROTOZOAN diseases ,LEISHMANIA donovani ,DRUG development ,APOPTOSIS ,LYMPHOPROLIFERATIVE disorders ,T cells - Abstract
Visceral leishmaniasis (VL) is a life-threatening protozoal infection chiefly impinging the rural and poor population in the tropical and sub-tropical countries. The deadly affliction is rapidly expanding after its association with AIDS, swiftly defying its status of a neglected disease. Despite successful formulation of vaccine against canine leishmaniasis, no licensed vaccine is yet available for human VL, chemotherapy is in appalling state, and the development of new candidate drugs has been painfully slow. In face of lack of proper incentives, immunostimulatory plant preparations owing antileishmanial efficacy bear potential to rejuvenate awful antileishmanial chemotherapy. We have earlier reported profound leishmanicidal activity of Piper nigrum hexane (PNH) seeds and P. nigrum ethanolic (PNE) fractions derived from P. nigrum seeds against Leishmania donovani promastigotes and amastigotes. In the present study, we illustrate that the remarkable anti-promastigote activity exhibited by PNH and PNE is mediated via apoptosis as evidenced by phosphatidylserine externalization, DNA fragmentation, arrest in sub G0/G1 phase, loss of mitochondrial membrane potential and generation of reactive oxygen species. Further, P. nigrum bioactive fractions rendered significant protection to L. donovani infected BALB/c mice in comparison to piperine, a known compound present in Piper species. The substantial therapeutic potential of PNH and PNE was accompanied by elicitation of cell-mediated immune response. The bioactive fractions elevated the secretion of Th1 (INF-γ, TNF-α, and IL-2) cytokines and declined IL-4 and IL-10. PNH and PNE enhanced the production of IgG2a, upregulated the expression of co-stimulatory molecules CD80 and CD86, augmented splenic CD4
+ and CD8+ T cell population, induced strong lymphoproliferative and DTH responses and partially stimulated NO production. PNH and PNE were devoid of any hepatic or renal toxicity. These encouraging findings merit further exploration of P. nigrum bioactive fractions as a source of potent and non-toxic antileishmanials. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
12. Leishmanicidal activity of Piper nigrum bioactive fractions is interceded via apoptosis in vitro and substantiated by Th1 immunostimulatory potential in vivo
- Author
-
Garima eChouhan, Mohammad eIslamuddin, Muzamil Yaqub Want, Hani A Ozbak, Hassan A Hemeg, DINKAR eSAHAL, and Farhat eAfrin
- Subjects
Apoptosis ,Leishmania donovani ,Piper nigrum ,Visceral leishmaniasis ,immunomodulatory ,antileishmanial ,Microbiology ,QR1-502 - Abstract
VL is a life-threatening protozoal infection chiefly impinging the rural and poor population in the tropical and sub-tropical countries. The deadly affliction is rapidly expanding after its association with AIDS, swiftly defying its status of a neglected disease. Despite successful formulation of vaccine against canine leishmaniasis, no licensed vaccine is yet available for human VL, chemotherapy is in appalling state, and the development of new candidate drugs has been painfully slow. In face of lack of proper incentives, immunostimulatory plant preparations owing antileishmanial efficacy bear potential to rejuvenate awful antileishmanial chemotherapy. We have earlier reported profound leishmanicidal activity of P. nigrum seeds hexane (PNH) and P. nigrum ethanolic (PNE) fractions derived from P. nigrum seeds against Leishmania donovani promastigotes and amastigotes. In the present study, we illustrate that the remarkable anti-promastigote activity exhibited by PNH and PNE is mediated via apoptosis as evidenced by phosphatidylserine externalization, DNA fragmentation, arrest in sub G0/G1 phase, loss of mitochondrial membrane potential and generation of reactive oxygen species. Further, P. nigrum bioactive fractions rendered significant protection to L. donovani infected BALB/c mice in comparison to piperine, a known compound present in Piper species. The substantial therapeutic potential of PNH and PNE was accompanied by elicitation of cell-mediated immune response. The bioactive fractions elevated the secretion of Th1 (INF-γ, TNF-α and IL-2) cytokines and declined IL-4 and IL-10. PNH and PNE enhanced the production of IgG2a, upregulated the expression of co-stimulatory molecules CD80 and CD86, augmented splenic CD4+ and CD8+ T cell population, induced strong lymphoproliferative and DTH responses and partially stimulated NO production. PNH and PNE were devoid of any hepatic or renal toxicity. These encouraging findings merit further exploration of P. nigrum bioactive fractions as a source of potent and non-toxic antileishmanials.
- Published
- 2015
- Full Text
- View/download PDF
13. Antileishmanial activity and immunomodulatory effect of secosubamolide, a butanolide isolated from Nectandra oppositifolia (Lauraceae)
- Author
-
João Henrique G. Lago, Geanne A. Alves Conserva, Andrés Jimenez Galisteo, Andre G. Tempone, and Thais A. Costa-Silva
- Subjects
lcsh:Arctic medicine. Tropical medicine ,Immunomodulatory ,lcsh:RC955-962 ,Nectandra oppositifolia ,Context (language use) ,Toxicology ,lcsh:RA1190-1270 ,lcsh:Zoology ,parasitic diseases ,medicine ,lcsh:QL1-991 ,Antileishmanial ,Cytotoxicity ,Amastigote ,IC50 ,lcsh:Toxicology. Poisons ,biology ,Traditional medicine ,Secosubamolide ,Chemistry ,Leishmania (L.) infantum chagasi ,Lauraceae ,medicine.disease ,biology.organism_classification ,Leishmania ,In vitro ,Infectious Diseases ,Visceral leishmaniasis ,Animal Science and Zoology ,Parasitology - Abstract
Background: Visceral leishmaniasis is a complex neglected tropical disease caused by Leishmania donovani complex. Its current treatment reveals strong limitations, especially high toxicity. In this context, natural products are important sources of new drug alternatives for VL therapy. Therefore, the antileishmanial and immunomodulatory activity of compounds isolated from Nectandra oppositifolia (Lauraceae) was investigated herein. Methods: The n-hexane extract from twigs of N. oppositifolia were subjected to HPLC/HRESIMS and bioactivity-guided fractionation to afford compounds 1 and 2 which were evaluated in vitro against Leishmania (L.) infantum chagasi and NCTC cells. Results: The n-hexane extract displayed activity against L. (L.) infantum chagasi and afforded isolinderanolide E (1) and secosubamolide A (2), which were effective against L. (L.) infantum chagasi promastigotes, with IC50 values of 57.9 and 24.9 µM, respectively. Compound 2 was effective against amastigotes (IC50 = 10.5 µM) and displayed moderate mammalian cytotoxicity (CC50 = 42 µM). The immunomodulatory studies of compound 2 suggested an anti-inflammatory activity, with suppression of IL-6, IL-10, TNF with lack of nitric oxide. Conclusion: This study showed the antileishmanial activity of compounds 1 and 2 isolated from N. oppositifolia. Furthermore, compound 2 demonstrated an antileishmanial activity towards amastigotes associated to an immunomodulatory effect.
- Published
- 2019
14. ANTILEISHMANIAL ACTIVITY OF A FORMULATION OF 2-N-PROPYLQUINOLINE BY ORAL ROUTE IN MICE MODEL.
- Author
-
Campos, Vieira N., Vacus, J., Fournet, A., Baudouin, R., Bories, C., Séon-Méniel, B., Figadère, B., and Loiseau, P. M.
- Subjects
VISCERAL leishmaniasis ,LEISHMANIASIS ,SALT ,PARASITES ,DRUGS ,PESTICIDE formulation - Abstract
The article presents a study which prepared a formulation for 2-n-propylquinoline, a drug-candidate for the treatment of visceral leishmaniosis in pre-clinical development. A 2-n-propylquinoline formulation as camphorsulfonic salt was prepared and characterised. The study found that the salt formulation did not alter the activity of the 2-n-propylquinoline and reduced the parasite burden of 76% compared to 89% for milfosine. The formulation also resulted in a suitable drugability of 2-n-propylquinoline for further studies.
- Published
- 2011
- Full Text
- View/download PDF
15. Erratum to: Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo
- Author
-
Garima Chouhan, Mohammad Islamuddin, Muzamil Y. Want, Malik Z. Abdin, Hani A. Ozbak, Hassan A. Hemeg, Dinkar Sahal, and Farhat Afrin
- Subjects
Visceral Leishmaniasis ,Leishmanicidal ,Infectious Diseases ,Immunomodulatory ,Azadirachta indica ,Research ,Parasitology ,Apoptosis ,Antileishmanial ,Immunopotentiating ,Leishmania donovani ,Immunostimulatory - Abstract
Background Exploration of immunomodulatory antileishmanials of plant origin is now being strongly recommended to overcome the immune suppression evident during visceral leishmaniasis (VL) and high cost and toxicity associated with conventional chemotherapeutics. In accordance, we assessed the in vitro and in vivo antileishmanial and immunomodulatory potential of ethanolic fractions of Azadirachta indica leaves (ALE) and seeds (ASE). Methods A. indica fractions were prepared by sequential extraction of the powdered plant parts in hexane, ethanol and water. Erythrosin B staining was employed to appraise the anti-promastigote potential of ALE and ASE. Cytostatic or cytocidal mode of action was ascertained and alterations in parasite morphology were depicted under oil immersion light microscopy. Study of apoptotic correlates was performed to deduce the mechanism of induced cell death and anti-amastigote potential was assessed in Leishmania parasitized RAW 264.7 macrophages. In vivo antileishmanial effectiveness was evaluated in L. donovani infected BALB/c mice, accompanied by investigation of immunomodulatory potential of ALE and ASE. Adverse toxicity of the bioactive fractions against RAW macrophages was studied by MTT assay. In vivo side effects on the liver and kidney functions were also determined. Plant secondary metabolites present in ALE and ASE were analysed by Gas chromatography–mass spectrometry (GC-MS). Results ALE and ASE (500 μg ml−1) exhibited leishmanicidal activity in a time- and dose-dependent manner (IC50 34 and 77.66 μg ml−1, respectively) with alterations in promastigote morphology and induction of apoptosis. ALE and ASE exerted appreciable anti-amastigote potency (IC50 17.66 and 24.66 μg ml−1, respectively) that was coupled with profound in vivo therapeutic efficacy (87.76% and 85.54% protection in liver and 85.55% and 83.62% in spleen, respectively). ALE exhibited minimal toxicity with selectivity index of 26.10 whereas ASE was observed to be non-toxic. The bioactive fractions revealed no hepato- and nephro-toxicity. ALE and ASE potentiated Th1-biased cell-mediated immunity along with upregulation of INF-γ, TNF-α and IL-2 and decline in IL-4 and IL-10 levels. GC-MS analysis revealed several compounds that may have contributed to the observed antileishmanial effect. Conclusion Dual antileishmanial and immunostimulatory efficacy exhibited by the bioactive fractions merits their use alone or as adjunct therapy for VL. Electronic supplementary material The online version of this article (doi:10.1186/s13071-015-0788-3) contains supplementary material, which is available to authorized users.
- Published
- 2016
16. Corrigendum: Leishmanicidal Activity of Piper nigrum Bioactive Fractions is Interceded via Apoptosis In Vitro and Substantiated by Th1 Immunostimulatory Potential In Vivo
- Author
-
Garima eChouhan, Mohammad eIslamuddin, Muzamil Yaqub Want, Hani A Ozbak, Hassan A Hemeg, DINKAR eSAHAL, and Farhat eAfrin
- Subjects
Microbiology (medical) ,Population ,lcsh:QR1-502 ,Leishmania donovani ,antileishmanial ,leishmanicidal ,Pharmacology ,Microbiology ,lcsh:Microbiology ,chemistry.chemical_compound ,Immune system ,medicine ,Amastigote ,education ,immunomodulatory ,Original Research ,Visceral leishmaniasis ,chemistry.chemical_classification ,Reactive oxygen species ,education.field_of_study ,biology ,apoptosis ,Correction ,biology.organism_classification ,medicine.disease ,chemistry ,Apoptosis ,Piperine ,Immunology ,Piper nigrum - Abstract
Visceral leishmaniasis (VL) is a life-threatening protozoal infection chiefly impinging the rural and poor population in the tropical and sub-tropical countries. The deadly affliction is rapidly expanding after its association with AIDS, swiftly defying its status of a neglected disease. Despite successful formulation of vaccine against canine leishmaniasis, no licensed vaccine is yet available for human VL, chemotherapy is in appalling state, and the development of new candidate drugs has been painfully slow. In face of lack of proper incentives, immunostimulatory plant preparations owing antileishmanial efficacy bear potential to rejuvenate awful antileishmanial chemotherapy. We have earlier reported profound leishmanicidal activity of Piper nigrum hexane (PNH) seeds and P. nigrum ethanolic (PNE) fractions derived from P. nigrum seeds against Leishmania donovani promastigotes and amastigotes. In the present study, we illustrate that the remarkable anti-promastigote activity exhibited by PNH and PNE is mediated via apoptosis as evidenced by phosphatidylserine externalization, DNA fragmentation, arrest in sub G0/G1 phase, loss of mitochondrial membrane potential and generation of reactive oxygen species. Further, P. nigrum bioactive fractions rendered significant protection to L. donovani infected BALB/c mice in comparison to piperine, a known compound present in Piper species. The substantial therapeutic potential of PNH and PNE was accompanied by elicitation of cell-mediated immune response. The bioactive fractions elevated the secretion of Th1 (INF-γ, TNF-α, and IL-2) cytokines and declined IL-4 and IL-10. PNH and PNE enhanced the production of IgG2a, upregulated the expression of co-stimulatory molecules CD80 and CD86, augmented splenic CD4(+) and CD8(+) T cell population, induced strong lymphoproliferative and DTH responses and partially stimulated NO production. PNH and PNE were devoid of any hepatic or renal toxicity. These encouraging findings merit further exploration of P. nigrum bioactive fractions as a source of potent and non-toxic antileishmanials.
- Published
- 2015
17. Understanding the characteristics of phytofabricated silver nanoparticles and their leishmanicidal potential against Indian strain of Leishmania donovani.
- Author
-
Roy Chowdhury, Dibyapriya, Pramanik, Pijush Kanti, Ghosh, Priyanka, Devgupta, Pujayita, and Chakraborti, Tapati
- Subjects
LEISHMANIA donovani ,MILTEFOSINE ,FLUORESCENCE spectroscopy ,ZETA potential ,CARBOXYL group ,SILVER nanoparticles ,NANOPARTICLES analysis ,MONODISPERSE colloids - Abstract
The present study was implemented to synthesize green silver nanoparticles from aqueous leaf extract of Nyctanthes arbor-tristis (AgNP
NA s) and to analyze their physicochemical properties in evaluating their antileishmanial activity. Formation of AgNPNA s from leaf extract (LE) was evidenced by the change of peak intensity in the fluorescence spectrum. The particles were nearly monodispersed (PDI = 0.134) with hydrodynamic diameter of 67.83 nm and appeared quite stable (zeta potential = −19.1 mV). FESEM study demonstrated nearly spherical shape of AgNPNA s and apparently smooth surface area was identified by AFM. The diameter of AgNPNA s (~ 21 nm) was measured by HRTEM. The amorphous crystal nature, polycrystallinity and low grain size of AgNPNA s were comprehended by the XRD. The crystalline nature was supported from SAED profile. The EDX spectra identified the constituents of AgNPNA s whereas the XPS spectra unraveled the Ag2 O state. The FTIR analysis implemented the phytofabricating agent(s) to be attached to the Ag0 via carboxyl group. The leishmanicidal activity of AgNPNA s on Leishmania donovani (MHOM/IN/1983/AG83) was compared with commercial silver nanoparticles (AgNPCO s), AgNO3 , miltefosine and leaf extract (LE). The AgNO3 (IC50 = 0.469 ± 0.116 μg/ml), AgNPCO s (IC50 = 4.74 ± 0.221 μg/ml), miltefosine (IC50 = 0.87 ± 0.038 μg/ml) proved their better leishmanicidal efficacy than AgNPNA s (IC50 = 11.46 ± 0.120 μg/ml) and LE was found to be incompetent as parasiticidal. However, AgNPNA s showed greater safety level (IC50 = 136.33 ± 0.881 μg/ml) in normal macrophages (Raw 264.7) than AgNO3 (IC50 = 1.81 ± 0.133 μg/ml), AgNPCO s (IC50 = 10.06 ± 0.719 μg/ml) and miltefosine (IC50 = 18.73 ± 0.9 μg/ml). Altogether, this study revealed the physicochemical properties of AgNPNA s and their biocompatibility in killing L. donovani promastigotes indicating their new identity as potential antileishmanial agent. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
18. Bio-guided isolation of anti-leishmanial natural products from Diospyros gracilescens L. (Ebenaceae).
- Author
-
Njanpa, Cyrille Armel N., Wouamba, Steven Collins N., Yamthe, Lauve Rachel T., Dize, Darline, Tchatat, Brice Mariscal T., Tsouh, Patrick Valère F., Pouofo, Michel Nguiam, Jouda, Jean Bosco, Ndjakou, Bruno Lenta, Sewald, Norbert, Kouam, Simeon Fogue, and Boyom, Fabrice Fekam
- Subjects
ANTIPROTOZOAL agents ,IN vitro studies ,LEISHMANIASIS ,MEDICINAL plants ,BIOLOGICAL products ,ONE-way analysis of variance ,DRUG design ,PHYTOCHEMICALS ,MASS spectrometry ,PLANT extracts ,MOLECULAR structure ,COLORIMETRY ,PARASITES ,CHROMATOGRAPHIC analysis ,DATA analysis software ,DRUG toxicity - Abstract
Background: Plants represent an intricate and innovative source for the discovery of novel therapeutic remedies for the management of infectious diseases. The current study aimed at discovering new inhibitors of Leishmania spp., using anti-leishmanial activity-guided investigation approach of extracts from Diospyros gracilescens Gürke (1911) (Ebenaceae), targeting the extracellular (promastigotes) and intracellular (amastigotes) forms of Leishmania donovani. Methods: The plant extracts were prepared by maceration using H
2 0: EtOH (30:70, v/v) and further fractionated using a bio-guided approach. Different concentrations of D. gracilescens extracts, fractions and isolated compounds were tested in triplicate against L. donovani promastigotes and amastigotes in vitro. The antileishmanial potency and cytotoxicity on RAW 264.7 cells were determined using the resazurin colorimetric assay. The time kill kinetic profile of the most active sample was also investigated. The structures of all compounds were elucidated on the basis of extensive spectroscopic analyses, including 1D and 2D NMR, and HR-ESI-MS and by comparison of their data with those reported in the literature. Results: The hydroethanolic crude extract of D. gracilescens trunk showed the most potent antileishmanial activity (IC50 = 5.84 μg/mL). Further fractionation of this extract led to four (4) fractions of which, the hexane fraction showed the most potent activity (IC50 = 0.79 μg/mL), and seven (07) compounds that exhibited moderate potency (IC50 = 13.69–241.71 μM) against L. donovani. Compound 1-deoxyinositol (7) inhibited the promastigote and amastigote forms of L. donovani with IC50 values of 241.71 μM and 120 μM respectively and also showed the highest selectivity against L. donovani promastigotes (SI > 5.04). To the best of our knowledge, the antileishmanial activity of this compound is being reported here for the first time. The promising hexane fraction showed significant inhibition of parasites growth at different concentrations, but with no evidence of cidal effect over an exposure period of 120 h. Conclusions: The results obtained indicated that the hydroethanolic extract from the D. gracilescens trunk and the derived hexane fraction have very potent inhibitory effect on cultivated promastigotes and amastigotes of L. donovani parasite. The isolated compounds showed a lesser extent of potency and selectivity. However, further structure-activity-relationship studies of 1-deoxyinositol could lead to more potent and selective hit derivatives of interest for detailed drug discovery program against visceral leishmaniasis. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
19. Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs
- Author
-
Yunus M. Siddiqui, Ahmed A. Al-Qahtani, Ola A. El-Sayed, Adnan A. Bekhit, Hassan Y. Aboul-Enein, and Mohammed N. Al-Ahdal
- Subjects
Pharmacology ,Leishmania donovani ,Pharmaceutical Science ,Leishmaniasis ,Biology ,medicine.disease ,biology.organism_classification ,In vitro ,Microbiology ,Visceral leishmaniasis ,Antiparasite ,Thiadiazoles ,Immunology ,parasitic diseases ,medicine ,Parasite hosting ,Original Article ,Antileishmanial - Abstract
Leishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand flies and replicates intracellularly in their mammalian host cells. The emergence of drug-resistant strains has hampered efforts to control the spread of the disease worldwide. Forty-four 1,3,4-thiadiazole derivatives and related compounds were tested in vitro for possible anti-leishmanial activity against the promastigotes of L. donovani. Micromolar concentrations of these agents were used to study the inhibition of multiplication of L. donovani promastigotes. Seven compounds were identified with potential antigrowth agents of the parasite. Compound 4a was the most active at 50μM followed by compound 3a. These compounds could prove useful as a future alternative for the control of visceral leishmaniasis.
- Full Text
- View/download PDF
20. In vitro antileishmanial activity of Aloe vera leaf exudate: A potential herbal therapy in leishmaniasis.
- Author
-
Dutta, Avijit, Mandal, Goutam, Mandal, Chitra, and Chatterjee, Mitali
- Abstract
Aloe vera has wide spread use in health products, and despite several reports on the whole plant and inner gel, little work has been performed on the leaf exudate. Our aim was to evaluate the in vitro efficacy of Aloe vera leaf exudate (AVL) in leishmaniasis. Irrespective of the disease manifestation, promastigotes from strains responsible for cutaneous, mucocutaneous, and visceral leishmaniasis were susceptible to AVL and their IC
50 ranged from 100 to 180 μg/ml. In axenic amastigotes cultured from a L. donovani strain 2001 responsible for visceral leishmaniasis, the IC50 was 6.0 μg/ml. AVL caused activation of host macrophages evident by an increased release of members of reactive oxygen species that was attenuated by preincubation with free radical scavengers. Collectively, our data indicates that AVL, via its direct leishmanicidal activity which can be further enhanced by activation of host macrophages, is an effective antileishmanial agent meriting further pharmacological investigations. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
21. A new approach for the delivery of artemisinin: Formulation, characterization, and ex-vivo antileishmanial studies.
- Author
-
Want, Muzamil Yaqub, Islamuddin, Mohammad, Chouhan, Garima, Dasgupta, Anjan Kumar, Chattopadhyay, Asoke Prasun, and Afrin, Farhat
- Subjects
- *
ARTEMISININ , *DRUG synergism , *DRUG efficacy , *LEISHMANIA , *DRUG bioavailability , *VISCERAL leishmaniasis - Abstract
Hypothesis Artemisinin, a potential antileishmanial compound with poor bioavailability and stability has limited efficacy in visceral leishmaniasis. Encapsulating artemisinin into poly lactic-co glycolic nanoparticles may improve its effectiveness and reduce toxicity. Experiments Artemisinin-loaded nanoparticles were prepared, optimized (using Box-Behnken design) and characterized by dynamic light scattering technique, Atomic force microscopy (AFM), Transmission electron microscopy (TEM) and Fourier Transform-Infra Red spectroscopy. Release kinetics of artemisinin from optimized nanoformulation was studied by dialysis method at pH 7.4 and 5.5. Cytotoxicity and antileishmanial activity of these nanoparticles was tested on murine macrophages by MTT assay and macrophage-infested Leishmania donovani amastigotes ex vivo, respectively. Findings Artemisinin-loaded nanoparticles were 221 ± 14 nm in diameter, with polydispersity index, zeta potential, drug loading and entrapment efficiency of 0.1 ± 0.015, -9.07 ± 0.69 mV, 28.03 ± 1.14 and 68.48 ± 1.97, respectively. AFM and TEM studies indicated that the particles were spherical in shape. These colloidal particles showed a sustained release pattern in vitro. Treatment with artemisinin-loaded nanoparticles significantly reduced the number of amastigotes per macrophage and percent infected macrophages ex vivo compared to free artemisinin. These nanoparticles were also non-toxic to macrophages compared to artemisinin alone. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
22. Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors.
- Author
-
Camargo, Priscila Goes, dos Santos, Carine Ribeiro, Girão Albuquerque, Magaly, Rangel Rodrigues, Carlos, and Lima, Camilo Henrique da Silva
- Subjects
MOLECULAR dynamics ,ARGINASE ,LEISHMANIA ,ALLOSTERIC enzymes ,PROTOZOAN diseases ,MOLECULAR interactions - Abstract
Leishmaniasis is a disease caused by a protozoan of the genus Leishmania, affecting millions of people, mainly in tropical countries, due to poor social conditions and low economic development. First-line chemotherapeutic agents involve highly toxic pentavalent antimonials, while treatment failure is mainly due to the emergence of drug-resistant strains. Leishmania arginase (ARG) enzyme is vital in pathogenicity and contributes to a higher infection rate, thus representing a potential drug target. This study helps in designing ARG inhibitors for the treatment of leishmaniasis. Py-CoMFA (3D-QSAR) models were constructed using 34 inhibitors from different chemical classes against ARG from L. (L.) amazonensis (LaARG). The 3D-QSAR predictions showed an excellent correlation between experimental and calculated pIC
50 values. The molecular docking study identified the favorable hydrophobicity contribution of phenyl and cyclohexyl groups as substituents in the enzyme allosteric site. Molecular dynamics simulations of selected protein–ligand complexes were conducted to understand derivatives' interaction modes and affinity in both active and allosteric sites. Two cinnamide compounds, 7g and 7k, were identified, with similar structures to the reference 4h allosteric site inhibitor. These compounds can guide the development of more effective arginase inhibitors as potential antileishmanial drugs. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
23. Dual Antitubercular and Antileishmanial Profiles of Quinoxaline Di- N -Oxides Containing an Amino Acidic Side Chain.
- Author
-
González, Juan F., Dea-Ayuela, María-Auxiliadora, Huck, Lena, Orduña, José María, Bolás-Fernández, Francisco, de la Cuesta, Elena, Haseen, Nazia, Mohammed, Ashraf Ali, and Menéndez, J. Carlos
- Subjects
QUINOXALINES ,LEISHMANIA donovani ,STRUCTURE-activity relationships ,MYCOBACTERIUM tuberculosis ,MILTEFOSINE - Abstract
We present a new category of quinoxaline di-N-oxides (QdNOs) containing amino acid side chains with dual antituberculosis and antileishmanial activity. These compounds were synthesized by combining a regioselective 2,5-piperazinedione opening and a Beirut reaction and were screened for their activity against Mycobacterium tuberculosis and the promastigote and amastigote forms of representative species of the Leishmania genus. Most QdNOs exhibited promising antitubercular activity with IC
50 values ranging from 4.28 to 49.95 μM, comparable to clinically established drugs. Structure–activity relationship analysis emphasized the importance of substituents on the aromatic ring and the side chain. Antileishmanial tests showed that some selected compounds exhibited activity comparable to the positive control miltefosine against promastigotes of Leishmania amazonensis and Leishmania donovani. Notably, some compounds were found to be also more potent and less toxic than miltefosine in intracellular amastigote assays against Leishmania amazonensis. The compound showing the best dual antitubercular and leishmanicidal profile and a good selectivity index, 4h, can be regarded as a hit compound that opens up new opportunities for the development of integrated therapies against co-infections. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
24. Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum.
- Author
-
Bodiwala, Hardik, Singh, Gaganmeet, Singh, Ranvir, Dey, Chinmoy, Sharma, Shyam, Bhutani, Kamlesh, and Singh, Inder
- Abstract
The n-hexane, ethyl acetate, methanol, and acetone extracts of Piper cubeba Linn. and P. retrofractum Vahl. (Piperaceae) were evaluated in vitro against promastigotes of Leishmania donovani, and all exhibited significant in vitro activity at 100 μg/ml. Two lignans, cubebin and hinokinin, were isolated from the hexane extract of P. cubeba; and one bis-epoxy lignan, (−)-sesamin, and two amides, pellitorine and piplartine, were isolated from the hexane and methanol extracts of P. retrofractum. Cubebin and piplartine showed significant antileishmanial activity in vitro at 100 μM and were further tested in vivo in a hamster model of visceral leishmaniasis. Piplartine showed activity at 30 mg/kg dose. This is the first report of antileishmanial activity of these two plants and their isolated constituents. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
25. Correlation between secondary metabolites of Iris confusa Sealy and Iris pseudacorus L. and their newly explored antiprotozoal potentials.
- Author
-
Abdel-Baki, Passent M., El-Sherei, Moshera M., Khaleel, Amal E., Abdel-Sattar, Essam, Salem, Mohamed A., and Okba, Mona M.
- Subjects
DRUG therapy for malaria ,ANTIPROTOZOAL agents ,IN vitro studies ,RESEARCH ,PROTOZOA ,MEDICINAL plants ,COMMUNICABLE diseases ,LEISHMANIASIS ,HIGH performance liquid chromatography ,MONOUNSATURATED fatty acids ,ANIMAL experimentation ,LEISHMANIA ,MACROPHAGES ,TREATMENT effectiveness ,PEARSON correlation (Statistics) ,CERAMIDES ,TRYPANOSOMIASIS ,PARASITIC diseases ,RESEARCH funding ,PLANT extracts ,MOLECULAR structure ,STATISTICAL correlation ,CELL lines ,CELL surface antigens ,PHOSPHOLIPIDS ,MICE ,METABOLITES ,IMMUNODIAGNOSIS ,SPHINGOLIPIDS ,PHARMACODYNAMICS - Abstract
Background: In the last few decades, the use of plant extracts and their phytochemicals as candidates for the management of parasitic diseases has increased tremendously. Irises are aromatic and medicinal plants that have long been employed in the treatment of different infectious diseases by traditional healers in many cultures. This study aims to explore the potential of three common Iris species (I. confusa Sealy, I. pseudacorus L. and I. germanica L.) against infectious diseases. Their in vitro antiprotozoal potency against Plasmodium falciparum, Trypanosoma brucei brucei, T. b. rhodesiense, T. cruzi and Leishmania infantum beside their cytotoxicity on MRC-5 fibroblasts and primary peritoneal murine macrophages were examined. Methods: The secondary metabolites of the tested extracts were characterized by UPLC-HRMS/MS and Pearsons correlation was used to correlate them with the antiprotozoal activity. Results: Overall, the non-polar fractions (NPF) showed a significant antiprotozoal activity (score: sc 2 to 5) in contrast to the polar fractions (PF). I. confusa NPF was the most active extract against P. falciparum [IC
50 of 1.08 μg/mL, selectivity index (S.I. 26.11) and sc 5] and L. infantum (IC50 of 12.7 μg/mL, S.I. 2.22 and sc 2). I. pseudacorus NPF was the most potent fraction against T. b. rhodesiense (IC50 of 8.17 μg/mL, S.I. 3.67 and sc 3). Monogalactosyldiacylglycerol glycolipid (18:3/18:3), triaceylglycerol (18:2/18:2/18:3), oleic acid, and triterpenoid irridals (spirioiridoconfal C and iso-iridobelamal A) were the top positively correlated metabolites with antiplasmodium and antileishmanial activities of I. confusa NPF. Tumulosic acid, ceramide sphingolipids, corosolic, maslinic, moreollic acids, pheophytin a, triaceylglycerols, mono- and digalactosyldiacylglycerols, phosphatidylglycerol (22:6/18:3), phosphatidylcholines (18:1/18:2), and triterpenoid irridal iso-iridobelamal A, were highly correlated to I. pseudacorus NPF anti- T. b. rhodesiense activity. The ADME study revealed proper drug likeness properties for certain highly corelated secondary metabolites. Conclusion: This study is the sole map correlating I. confusa and I. pseudacorus secondary metabolites to their newly explored antiprotozoal activity. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
26. Microgramma vacciniifolia Frond Lectin: In Vitro Anti-leishmanial Activity and Immunomodulatory Effects Against Internalized Amastigote Forms of Leishmania amazonensis.
- Author
-
de Souza Aguiar, Lethícia Maria, de Moraes Alves, Michel Muálem, Sobrinho Júnior, Enoque Pereira Costa, Paiva, Patrícia Maria Guedes, de Amorim Carvalho, Fernando Aécio, de Albuquerque, Lidiane Pereira, de Siqueira Patriota, Leydianne Leite, and Napoleão, Thiago Henrique
- Subjects
AMASTIGOTES ,LEISHMANIA ,PERITONEAL macrophages ,LEISHMANIASIS ,NATURAL products ,NITRIC oxide - Abstract
Purpose: The treatment of leishmaniasis, an anthropozoonosis caused by Leishmania protozoa, is limited by factors, such as adverse effects, toxicity, and excessive cost, which has highlighted the importance of novel drugs. In this context, natural products have been considered as sources of antileishmanial agents. This study investigated the leishmanicidal activity of Microgramma vacciniifolia frond lectin (MvFL) on promastigotes and amastigotes of Leishmania amazonensis. Methods: The effects of MvFL on promastigote proliferation and macrophage infection by amastigotes were evaluated and mean inhibitory concentrations (IC
50 ) were calculated. As a safety assessment, the hemolytic capacity of MvFL (6.25–200 µg/mL) against mouse and human erythrocytes was determined. Additionally, the ability of MvFL (6.25–100 µg/mL) to modulate lysosomal and phagocytic activities and the nitric oxide (NO) production by murine peritoneal macrophages was also investigated. Results: After 24 h, MvFL inhibited the proliferation of L. amazonensis promastigotes, with an IC50 of 88 µg/mL; however, hemolytic activity was not observed. MvFL also reduced macrophage infection by amastigotes with an IC50 of 52 µg/mL. Furthermore, treatment with MvFL reduced the number of amastigotes internalized by infected murine peritoneal macrophages by up to 68.9% within 48 h. At a concentration of 25 µg/mL, MvFL stimulated lysosomal activity of macrophages within 72 h, but did not alter phagocytic activity or induce NO production at any of the tested concentrations. Conclusion: MvFL exerts antileishmanial activity and further studies are needed to assess its therapeutic potential in in vivo experimental models of leishmaniasis. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
27. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
- Author
-
Manda, Sudhakar, Khan, Shabana I., Jain, Surendra K., Mohammed, Shabber, Tekwani, Babu L., Khan, Ikhlas A., Vishwakarma, Ram A., and Bharate, Sandip B.
- Subjects
- *
LEISHMANIASIS treatment , *TRYPANOSOMIASIS treatment , *TETRAHYDROCANNABINOL , *PROMASTIGOTE , *VISCERAL leishmaniasis , *MACROPHAGES , *CELL-mediated cytotoxicity , *THERAPEUTICS - Abstract
A series of N-substituted tetrahydro-β-carbolines were synthesized and screened for antileishmanial activity through an in vitro assay that involves promastigotes and axenic amastigotes of Leishmania donovani , the causative agent for visceral leishmaniasis. The thiophen-2-yl analogs 9b and 11f and naphthyl analog 11h were found to show significant activity against promastigotes with IC 50 values of 12.7, 9.1 and 22.1 μM, respectively. Analogs 9b and 11h were also effective against axenic amastigotes with IC 50 values of 62.8 and 87.6 μM, respectively. The antileishmanial activity of analogs was then tested in human macrophage cell line infected with L. donovani amastigotes and 2-naphthyl linked analog 11h was found to be effective with IC 50 value of 28.3 μM. Several analogs also displayed antitrypanosomal activity against Trypanosoma brucei , the causative agent for human African trypanosomiasis . Compounds 11e , 11f and 11h were more effective than others with IC 50 values of 1.0, 8.9 and 10.2 μM, respectively. All synthesized analogs were not cytotoxic towards mammalian cell lines including Vero (monkey kidney fibroblasts), HEPG2 (human hepatoma cells), LLC-PK 1 (pig kidney epithelial cells) and THP-1 (human macrophages). [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
28. Inhibition of growth of Leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs.
- Author
-
Al-Qahtani, Ahmed, Siddiqui, Yunus M., Bekhit, Adnan A., El-Sayed, Ola A., Aboul-Enein, Hassan Y., and Al-Ahdal, Mohammed N.
- Abstract
Abstract: Leishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand flies and replicates intracellularly in their mammalian host cells. The emergence of drug-resistant strains has hampered efforts to control the spread of the disease worldwide. Forty-four 1,3,4-thiadiazole derivatives and related compounds were tested in vitro for possible anti-leishmanial activity against the promastigotes of L. donovani. Micromolar concentrations of these agents were used to study the inhibition of multiplication of L. donovani promastigotes. Seven compounds were identified with potential antigrowth agents of the parasite. Compound 4a was the most active at 50μM followed by compound 3a. These compounds could prove useful as a future alternative for the control of visceral leishmaniasis. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
29. Synthesis, antileishmanial activity and molecular modeling of new 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives.
- Author
-
Mohammadi-Ghalehbin, Behnam, Shiran, Jafar Abbasi, Gholizadeh, Nastaran, and Razzaghi-Asl, Nima
- Abstract
Due to the lack of effective vaccine(s) against leishmania and also pharmacokinetics issues of current drugs, it is necessary to discover new antileishmanial agents. Within this particular study, a series of novel 1-aryl/alkyl-3-benzoyl/cyclopropanoyl thiourea derivatives were synthesized (yields 69–84%) and evaluated as antileishmanial compounds (1–11). Synthetic derivatives were subjected to in vitro antileishmanial assessment against Leishmania major promastigotes by colorimetric MTT assay. Compounds 3 (IC
50 38.54 µg/mL), 5 (IC50 84.75 µg/mL) and 10 (IC50 70.31 µg/mL) exhibited higher activities after 48 h but were less potent than amphotericin B (IC50 0.19 µg/mL). Antileishmanial activities indicated priority of 5-methyl-4-phenyl thiazole over furyl methyl substituents and 4-phenyl thiazole on thiourea nitrogen. N-myristoyltransferase (NMT) was selected as a validated L. major target for molecular docking studies. In silico results indicated the contribution of hydrophobic, π-stacking and H-bond interactions in binding to target. Most of the synthesized derivatives had lower binding affinities to human NMT (hNMT) than leishmanial enzyme. Docking conformations of top-ranked selective binders (compounds 3 and 5) were subjected to 50 ns MD simulations inside L. major HMT (LmNMT) active site. MD trajectories were used to extract RMSD, RMSF, Rg and durability of intramolecular/intermolecular H-bonds of the complex. It was observed that compound 3 escaped from LmNMT binding site during simulation period and no stable complex could be envisaged. Unlike 3, compound 5 attained stable binding conformation with converged stability parameters. Although mechanistic details for antileishmanial effects of synthesized derivatives are to be explored, current results may be implicated in further structure-guided approach toward potent antileishmanial agents. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
30. Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities.
- Author
-
Kapusterynska, Anna, Bijani, Christian, Paliwoda, Damian, Vendier, Laure, Bourdon, Valérie, Imbert, Nicolas, Cojean, Sandrine, Loiseau, Philippe Marie, Recchia, Deborah, Scoffone, Viola Camilla, Degiacomi, Giulia, Akhir, Abdul, Saxena, Deepanshi, Chopra, Sidharth, Lubenets, Vira, and Baltas, Michel
- Subjects
ANTIBACTERIAL agents ,ALDEHYDES ,HYDRAZINES ,GEOMETRIC shapes ,MYCOBACTERIUM tuberculosis ,HYDRAZINE ,HYDRAZONES ,AMIDES - Abstract
Hydrazone compounds represent an important area of research that includes, among others, synthetic approaches and biological studies. A series of 17 hydrazones have been synthesized by mechanochemical means. The fragments chosen were phenolic and furanyl aldehydes coupled with 12 heterocyclic hydrazines or hydrazinamides. All compounds can be obtained quantitatively when operating on a planetary ball mill and a maximum reaction time of 180 min (6 cycles of 30 min each). Complete spectroscopic analyses of hydrazones revealed eight compounds (3–5, 8–11, 16) present in one geometric form, six compounds (1, 2, 13–15) present in two isomeric forms, and three compounds (6, 7, 12) where one rotation is restricted giving rise to two different forms. The single crystal X-ray structure of one of the hydrazones bearing the isoniazid fragment (8) indicates a crystal lattice consisting of two symmetry-independent molecules with different geometries. All compounds obtained were tested for anti-infectious and antibacterial activities. Four compounds (1, 3, 5 and 8) showed good activity against Mycobacterium tuberculosis, and one (7) was very potent against Staphylococcus aureus. Most interesting, this series of compounds displayed very promising antileishmanial activity. Among all, compound 9 exhibited an IC
50 value of 0.3 µM on the Leishmania donovani intramacrophage amastigote in vitro model and a good selectivity index, better than miltefosine, making it worth evaluating in vivo. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
31. Research Advances on the Bioactivity of 1,2,3-Triazolium Salts.
- Author
-
Song, Jia, Lv, Jie, Jin, Jiamiao, Jin, Zhichao, Li, Tingting, and Wu, Jian
- Subjects
SALTS ,STRUCTURE-activity relationships ,ANTIBACTERIAL agents ,SYNTHETIC biology ,ANTIFUNGAL agents - Abstract
1,2,3-Triazolium salts have demonstrated significant potential in the fields of medicine and agriculture, exhibiting exceptional antibacterial, antifungal, anticancer, and antileishmanial properties. Moreover, these salts can be utilized as additives or components to produce nano- and fiber-based materials with antibacterial properties. In this review, we summarize several synthetic strategies to obtain 1,2,3-triazolium salts and the structures of 1,2,3-triazolium derivatives with biological activities in the domains of pharmaceuticals, pesticides, and functional materials. Additionally, the structure–activity relationship (SAR) of 1,2,3-triazolium salts with different biological activities has been analyzed. Finally, this review presents the potential applications and prospects of 1,2,3-triazolium salts in the fields of agriculture, medicine, and industrial synthesis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Constituents of the Stem Bark of Symphonia globulifera Linn. f. with Antileishmanial and Antibacterial Activities.
- Author
-
Nguengang, Ruland Tchuinkeu, Tchegnitegni, Billy Toussie, Nono, Eric Carly Nono, Bellier Tabekoueng, Georges, Fongang, Yannick Stéphane Fotsing, Bankeu, Jean Jules Kezetas, Chouna, Jean Rodolphe, Nkenfou, Céline Nguefeu, Fekam, Fabrice Boyom, Sewald, Norbert, and Lenta, Bruno Ndjakou
- Subjects
ANTIBACTERIAL agents ,HYDROXYBENZOPHENONES ,TOCOTRIENOL ,LEISHMANIA donovani ,BENZOPHENONES - Abstract
The chemical investigation of the n-hexane fraction from the methanol extract of the stem bark of Symphonia globulifera Linn f., which displayed good in vitro activity against Leishmania donovani NR-48822 promastigotes (IC
50 43.11 µg/mL), led to the isolation of three previously unreported polyprenylated benzophenones, guttiferone U (1), V (2)/W (3), and a new tocotrienol derivative named globuliferanol (4), along with 11 known compounds (5–15). Their structures were elucidated based on their NMR and MS data. Some isolated compounds were assessed for both their antileishmanial and cytotoxic activities against L. donovani and Vero cells, respectively. Guttiferone K (5) exhibited the best potency (IC50 3.30 μg/mL), but with low selectivity to Vero cells. The n-hexane fraction and some compounds were also assessed in vitro for their antibacterial activity against seven bacterial strains. All the samples exhibited moderate to potent antibacterial activity (MICs ≤ 15.6 µg/mL) against at least one of the tested strains. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
33. Antileishmanial activities of caffeic acid phenethyl ester loaded PLGA nanoparticles against Leishmania infantum promastigotes and amastigotes in vitro.
- Author
-
Abamor, Emrah Sefik
- Abstract
Objective To investigate and compare the antileishmanial effects of CAPE and (CAPE) PLGA NPs on Leishmania infantum ( L. infantum ) promastigotes and amastigotes in vitro . Methods Efficacies of CAPE, (CAPE) PLGA NPs and free PLGA nanoparticles (NPs) on promastigotes were evaluated using MTT and promastigote count assays, and their anti-amastigote effects were determined via infection index analysis. Griess reaction was also performed to calculate nitric oxide production of macrophages exposed to investigated molecules. Results It was determined that CAPE and (CAPE) PLGA NPs demonstrated significant inhibitory effects on L. infantum promastigotes and amastigotes, while free NPs did not exhibit any meaningful antileishmanial effectiveness. The IC 50 values of CAPE for L. infantum promastigotes and amastigotes were assessed as (51.0 ± 0.8) and (19.0 ± 1.4) μg/mL, respectively ( P < 0.05). On the other side, it was revealed that (CAPE) PLGA NPs had superior antileishmanial activity on both forms of parasites since its IC 50 values for L. infantum promastigotes and amastigotes were (32.0 ± 1.3) and (8.0 ± 0.9) μg/mL, respectively ( P < 0.05). It was also determined that both agents strongly stimulated nitric oxide production of macrophages. Conclusions The obtained results show that (CAPE) PLGA NPs have a great potential to be especially used in treatment of visceral leishmaniasis; however, in vivo antileishmanial screening of these molecules should be performed in the near future. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
34. Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition.
- Author
-
Istanbullu, Huseyin, Bayraktar, Gulsah, Karakaya, Gulsah, Akbaba, Hasan, Perk, Nami Ege, Cavus, Ibrahim, Podlipnik, Crtomir, Yereli, Kor, Ozbilgin, Ahmet, Debelec Butuner, Bilge, and Alptuzun, Vildan
- Subjects
- *
VECTOR-borne diseases , *PROTOZOAN diseases , *LEISHMANIASIS , *MOLECULAR docking , *VISCERAL leishmaniasis - Abstract
The leishmaniasis are a group of vector-borne diseases caused by a protozoan parasite from the genus Leishmania. In this study, a series of thiazolopyrimidine derivatives were designed and synthesized as novel antileishmanial agents with Lm PTR1 inhibitory activity. The final compounds were evaluated for their in vitro antipromastigote activity, Lm PTR1 and h DHFR enzyme inhibitory activities, and cytotoxicity on RAW264.7 and L929 cell lines. Based on the bioactivity results, three compounds, namely L24f , L24h and L25c , were selected for evaluation of their in vivo efficacy on CL and VL models in BALB/c mice. Among them, two promising compounds, L24h and L25c, showed in vitr o antipromastigote activity against L. tropica with the IC 50 values of 0.04 μg/ml and 6.68 μg/ml; against L. infantum with the IC 50 values of 0.042 μg/ml and 6.77 μg/ml, respectively. Moreover, the title compounds were found to have low in vitro cytotoxicity on L929 and RAW264.7 cell lines with the IC 50 14.08 μg/ml and 21.03 μg/ml, and IC 50 15.02 μg/ml and 8.75 μg/ml, respectively. Lm PTR1 enzyme inhibitory activity of these compounds was determined as 257.40 μg/ml and 59.12 μg/ml and their selectivity index (SI) over h DHFR was reported as 42.62 and 7.02, respectively. In vivo studies presented that L24h and L25c have a significant antileishmanial activity against footpad lesion development of CL and at weight measurement of VL group in comparison to the reference compound, Glucantime®. Also, docking studies were carried out with selected compounds and other potential Leishmania targets to detect the putative targets of the title compounds. Taken together, all these findings provide an important novel lead structure for the antileishmanial drug development. [Display omitted] • A series of thiazolopyrimidine derivatives were synthesized as novel antileishmanials. • L24f , L24h and L25c showed in vitro antipromastigote activity and low cytotoxicity. • L24f , L24h and L25c showed moderate Lm PTR1 inhibition and h DHFR selectivity. • L24h and L25c have shown in vivo activity on CL and VL models of BALB/c mice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Plants as Antileishmanial Agents: Current Scenario.
- Author
-
Ullah, Nazif, Nadhman, Akhtar, Siddiq, Sumaira, Mehwish, Shaila, Islam, Arshad, Jafri, Laila, and Hamayun, Muhammad
- Abstract
Leishmaniasis is a clinical manifestation caused by the parasites of the genus Leishmania. Plants are reservoirs of bioactive compounds, which are known to be chemically balanced, effective and least injurious as compared with synthetic medicines. The current resistance and the toxic effects of the available drugs have brought the trend to assess the antileishmanial effect of various plant extracts and their purified compound/s, which are summarized in this review. Moreover, it also highlights various traditional remedies used by local healers against leishmaniasis. A systematic cross-sectional study for antileishmanial activity of natural products was carried out using multiple literature databases. The records retrieved since 2000 till year 2016 were analysed and summarized in the form of comprehensive tables and graphs. Natural products are potential source of new and selective agents that can significantly contribute to primary healthcare and probably are promising substitutes of chemicals for the treatment of protozoan diseases like leishmaniasis. Where the researchers prefer to use alcoholic solvents for the extraction of antileishmanial agents from plants, most of the studies are limited to in vitro conditions majorly on using promastigote forms of Leishmania. Thus, there is a need to carry out such activities in vivo and in host macrophages. Further, there is a need of mechanistic studies that can help taking few of the promising pure compounds to clinical level. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
36. Cytotoxic and Antileishmanial Effects of the Monoterpene β-Ocimene.
- Author
-
Sousa, Julyanne Maria Saraiva de, Nunes, Thaís Amanda de Lima, Rodrigues, Raiza Raianne Luz, Sousa, João Paulo Araújo de, Val, Maria da Conceição Albuquerque, Coelho, Francisco Alex da Rocha, Santos, Airton Lucas Sousa dos, Maciel, Nicolle Barreira, Souza, Vanessa Maria Rodrigues de, Machado, Yasmim Alves Aires, Sousa, Paulo Sérgio de Araújo, Araújo, Alyne Rodrigues de, Rocha, Jefferson Almeida, Sousa, Damião Pergentino de, Silva, Marcos Vinicius da, Arcanjo, Daniel Dias Rufino, and Rodrigues, Klinger Antônio da Franca
- Subjects
MONOTERPENES ,LYSOSOMES ,ATOMIC force microscopy ,CELL morphology ,REACTIVE oxygen species ,ESSENTIAL oils ,MEMBRANE permeability (Biology) - Abstract
Leishmaniasis is a group of infectious-parasitic diseases with high mortality rates, and endemic in many regions of the globe. The currently available drugs present serious problems such as high toxicity, costs, and the emergence of drug resistance. This has stimulated research into new antileishmania drugs based on natural products and their derivatives. β-Ocimene is a monoterpene found naturally in the essential oils of many plant species which presents antileishmanial activity, and which has not yet been evaluated for its potential to inhibit the etiological agent of leishmaniasis. The aim of this work was to evaluate the activity of β-ocimene against Leishmania amazonensis, its cytotoxicity, and potential mechanisms of action. β-Ocimene presented direct activity against the parasite, with excellent growth inhibition of promastigotes (IC
50 = 2.78 μM) and axenic amastigotes (EC50 = 1.12 μM) at concentrations non-toxic to RAW 264.7 macrophages (CC50 = 114.5 µM). The effect is related to changes in membrane permeability and resulting abnormalities in the parasitic cell shape. These were, respectively, observed in membrane integrity and atomic force microscopy assays. β-Ocimene was also shown to act indirectly, with greater activity against intra-macrophagic amastigotes (EC50 = 0.89 μM), increasing TNF-α, nitric oxide (NO), and reactive oxygen species (ROS), with lysosomal effects, as well as promoting decreases in IL-10 and IL-6. Against intra-macrophagic amastigote forms the selectivity index was higher than the reference drugs, being 469.52 times more selective than meglumine antimoniate, and 42.88 times more selective than amphotericin B. Our results suggest that β-ocimene possesses promising in vitro antileishmania activity and is a potential candidate for investigation in in vivo assays. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
37. In vitro/in vivo assessment and cellular mechanisms of Astragalus spinosus Extract againstLeishmania major.
- Author
-
Almohammed, Hamdan and Alanazi, Abdullah
- Subjects
ASTRAGALUS (Plants) ,PARASITES ,LEISHMANIA ,LEISHMANIA major ,AMASTIGOTES - Abstract
Background: In recent years, increasing resistance to synthetic agents, their long-term treatment, and lasting side effects, has faced many problems in treatment of leishmaniasis; so that finding a new high-efficacy antileishmanial drug with minimal side effects seems very necessary. This experimental study was aimed to evaluate the in vitro and in vivo leishmanicidal activity and cellular mechanisms of Astraglus spinosus methanolic extract (ASME) against Leishmania major infection. Materials and Methods: In vitro antileishmanial effect of ASME was evaluated on intracellular amastigotes of L. major in macrophage model. The effect of ASME on the NO production of macrophage cells was determined based on the Griess reaction for nitrites. Effect of ASME on the caspase-3-like activity of L. major promastigotes was performed according to the measuring the rate of color spectrophotometry. The 50% cytotoxic concentrations (CC
50 ) of the ASME on macrophages were measured to assess the cytotoxicity of ASME. In addition, in vivo effects of ASME were evaluated in infected BALB/c mice by measuring of the diameter of CL lesions and parasite load in the tested mice before and after 28 days of therapy. Results: The mean number of intracellular amastigotes of L. major significantly (P < 0.001) decreased with the IC50 value of 36.9 ± 3.012 μg/mL and 44.3 ± 3.012 μg/mL for ASME and MA, respectively. Although more NO was produced by increasing the concentrations of the ASME, but, a notable rise was detected at the IC50 (P < 0.001). ASME especially at the concentrations of ½ IC50 and IC50 significantly provoked the caspase-3 activation, by 10.3%, 25.6%, and 29.8%, respectively. The measured CC50 value of ASME and MA was 463.3 μg/mL and 835 μg/mL, respectively. Treatment of the infected mice with various doses of ASME (50 and 100 mg/kg for 28 days), markedly declined the mean diameter of the CL lesions and parasite load in tested mice. Conclusion: Based on the obtained results, ASME can be considered as a promising herbal drug candidate for the isolation and production of a new alternative agent for CL treatment. As a result, this survey presented adequate results in the parasite eliminating in both in vitro and in vivo assay. Nevertheless, additional studies are needed to elucidate the accurate mechanisms of action of ASME and its effectiveness in clinical subjects. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
38. Bio-guided isolation of anti-leishmanial natural products from Diospyros gracilescens L. (Ebenaceae)
- Author
-
Cyrille Armel N. Njanpa, Steven Collins N. Wouamba, Lauve Rachel T. Yamthe, Darline Dize, Brice Mariscal T. Tchatat, Patrick Valère F. Tsouh, Michel Nguiam Pouofo, Jean Bosco Jouda, Bruno Lenta Ndjakou, Norbert Sewald, Simeon Fogue Kouam, and Fabrice Fekam Boyom
- Subjects
Diospyros gracilescens ,Ebenaceae ,Hexane fraction ,Isolated compounds ,Antileishmanial ,Cytotoxicity ,Other systems of medicine ,RZ201-999 - Abstract
Abstract Background Plants represent an intricate and innovative source for the discovery of novel therapeutic remedies for the management of infectious diseases. The current study aimed at discovering new inhibitors of Leishmania spp., using anti-leishmanial activity-guided investigation approach of extracts from Diospyros gracilescens Gürke (1911) (Ebenaceae), targeting the extracellular (promastigotes) and intracellular (amastigotes) forms of Leishmania donovani. Methods The plant extracts were prepared by maceration using H20: EtOH (30:70, v/v) and further fractionated using a bio-guided approach. Different concentrations of D. gracilescens extracts, fractions and isolated compounds were tested in triplicate against L. donovani promastigotes and amastigotes in vitro. The antileishmanial potency and cytotoxicity on RAW 264.7 cells were determined using the resazurin colorimetric assay. The time kill kinetic profile of the most active sample was also investigated. The structures of all compounds were elucidated on the basis of extensive spectroscopic analyses, including 1D and 2D NMR, and HR-ESI-MS and by comparison of their data with those reported in the literature. Results The hydroethanolic crude extract of D. gracilescens trunk showed the most potent antileishmanial activity (IC50 = 5.84 μg/mL). Further fractionation of this extract led to four (4) fractions of which, the hexane fraction showed the most potent activity (IC50 = 0.79 μg/mL), and seven (07) compounds that exhibited moderate potency (IC50 = 13.69–241.71 μM) against L. donovani. Compound 1-deoxyinositol (7) inhibited the promastigote and amastigote forms of L. donovani with IC50 values of 241.71 μM and 120 μM respectively and also showed the highest selectivity against L. donovani promastigotes (SI > 5.04). To the best of our knowledge, the antileishmanial activity of this compound is being reported here for the first time. The promising hexane fraction showed significant inhibition of parasites growth at different concentrations, but with no evidence of cidal effect over an exposure period of 120 h. Conclusions The results obtained indicated that the hydroethanolic extract from the D. gracilescens trunk and the derived hexane fraction have very potent inhibitory effect on cultivated promastigotes and amastigotes of L. donovani parasite. The isolated compounds showed a lesser extent of potency and selectivity. However, further structure-activity-relationship studies of 1-deoxyinositol could lead to more potent and selective hit derivatives of interest for detailed drug discovery program against visceral leishmaniasis.
- Published
- 2021
- Full Text
- View/download PDF
39. Antitrypanosomal activity of new semi‐synthetic bergenin derivatives.
- Author
-
El‐Hawary, Seham S., Mohammed, Rabab, AbouZid, Sameh, Zaki, Mohamed A., Ali, Zeinab Y., Elwekeel, Ahlam, and Elshemy, Heba A. H.
- Subjects
ESTER derivatives - Abstract
Bergenin and 11‐O‐(4'‐O‐methyl galloyl)‐bergenin, previously isolated from Crassula capitella extract, were used as starting materials for the synthesis of eight derivatives; four derivatives 2a–2d were synthesized from bergenin through the formation of ester derivatives and four alkyl derivatives 4a–4d were synthesized from 11‐O‐(4′‐O‐methyl galloyl)‐bergenin. The structures of the synthesized analogues were confirmed upon 1H and 13C NMR spectroscopic elucidation. Antileishmanial and antitrypanosomal activities of the synthesized derivatives were evaluated, compounds 11‐O‐(3′,5′ di‐benzyl, 4′‐O‐methyl galloyl)‐8,10‐di‐O‐benzyl‐bergenin (4c) and 11‐O‐(3′,5′di‐4‐chlorobenzyl,4′‐O‐methyl galloyl)‐8,10di‐O‐4‐chlorobenzyl bergenin (4d) showed potent antitrypanosomal activity with IC50 values of 0.52 and 0.5 μM, respectively and IC90 values of 0.66 μM against T. brucei compared with IC50 and IC90 values of 21.7 and 50.3 μM for the positive control difluoromethylornithine. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Revisiting nature: a review of iridoids as a potential antileishmanial class.
- Author
-
Arraché Gonçalves, Guilherme, Eifler-Lima, Vera Lucia, and von Poser, Gilsane Lino
- Abstract
Leishmaniasis still stands as one of the most prevalent neglected tropical diseases in the least developed and emerging countries. The recommended therapeutic arsenal to treat leishmaniasis is characterized by several shortcomings, and resistance has already been reported. Hence, this dramatic background highlights the pressing need to develop novel, affordable, and safe antileishmanial drugs. Multiple classes of natural compounds have been reported to possess antileishmanial activity. Among these classes, iridoids stand out as a special type of monoterpenoids with diverse biological properties—including their antileishmanial potential. This review aims to discuss the available literature between 1991 and 2020 related to the antileishmanial activity of the iridoid class. Throughout the past decades, various investigations attributed antileishmanial action to assorted iridoid types, including inhibitory potential towards validated drug targets and immunomodulatory activity. The latter deserves special attention due to the ability of some iridoids to improve the host's immune response against parasites. It opens the possibility of iridoids become adjuncts in leishmaniasis treatments by improving the efficacy of currently employed drugs. Furthermore, the present study intends to provide a convenient visual representation of which iridoids and Leishmania spp. species have been most investigated as a guide for further researches. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Antileishmanial, antibacterial and cytotoxicity activity of the extracts, fractions, and compounds from the fruits and stem bark extracts of Pentadesma butyracea Sabine.
- Author
-
Garba, Jean Koffi, Nguengang, Ruland Tchuinkeu, Youmbi, Gwladys Tatiana, Menatche, Joel Njopnu, Ngansop, Cyrille Armel Njanpa, Bankeu, Jean Jules Kezetas, Chouna, Jean Rodolphe, Boyom, Fabrice Fekam, Sewald, Norbert, and Lenta, Bruno Ndjakou
- Subjects
ANTIBACTERIAL agents ,ENTEROBACTER cloacae ,SALMONELLA typhi ,STREPTOCOCCUS pneumoniae ,LEISHMANIA donovani ,COLUMN chromatography ,ENTEROBACTERIACEAE - Abstract
The search for antileishmanial plants used in traditional medicine led to the choice of CH
2 Cl2 –MeOH (1:1) crude extract of the fruits and stem bark of Pentadesma butyracea Sabine (Clusiaceae) which displayed good activity in vitro against Leishmania donovani 1S (MHOM/SD/62/1S) promastigotes during preliminary screening with IC50 values 5.96 and 26.43 μg mL−1 , respectively. The fractionation of both extracts using flash chromatography yielded active fractions with IC50 values ranging from 2.71 to 18.88 μg mL−1 . Fourteen compounds (1–14) were isolated from the obtained fractions using successive column chromatographies and their structures were elucidated based on the analysis of their NMR and MS data. Daphnifolin (1), epicathechin (3), α-mangostin (9) and 9-hydroxycalabaxanthone (14) exhibited potent antileismanial activity against L. donovani 1S (MHOM/SD/62/1S) promastigotes with IC50 values of 2.01, 9.09, 3.37, and 6.87 μg mL−1 , respectively and good selectivity towards Raw 264.7 macrophage cells (SI > 2.4). Extracts, fractions and some isolates were also assessed in vitro for their antibacterial activity against six bacterial strains [Salmonella typhi (CPC), Enterobacter cloacae (CPC), Pseudomonas aeruginosa HM801, Staphylococcus aureus ATCC 43300, Streptococcus pneumoniae ATCC 491619, Escherichia coli ATCC 25322] using serial microdilution method. Among the tested samples, the stem bark extract of P. butyracea as well as compounds 2 and 8 showed good to moderate activity against the aforementioned bacterial strains with MIC ≤ 250 μg mL−1 . [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
42. In vitro and in vivo leishmanicidal activity of Dysoxylum binectariferum and its fractions against Leishmania donovani.
- Author
-
Lakshmi, V., Pandey, K., Kapil, A., Singh, N., Samant, M., and Dube, A.
- Abstract
Abstract: The leishmanicidal effect of crude ethanolic extract of stem bark of Dysoxylum binectariferum and its fractions has been investigated against Leishmania donovani, the causative agent of visceral leishmaniasis. Ethanolic extract was lethal to promastigotes as well as amastigote forms in macrophage system at the concentration of 100μg/ml. Chloroform fraction significantly inhibited promastigote multiplication and was also active against amastigotes in infected J774A.1 macrophages at 100μg/ml. Hexane fraction was moderately active and the other fractions were inactive against both the forms. When tested in vivo in hamsters, ethanolic extract was toxic at 500mg/kg whereas exhibited marginal activity (67.7±5.3%) at 250mg/kg×5, p.o. on day 7 post treatment (p.t.) which increases slightly (69±4.7) by day 30 p.t. Chloroform and n-hexane fractions exhibited 64.3±4% and 47.8±4.6% parasite inhibition at the dose of 100mg/kg×5 p.o., respectively. The pure compound, rohitukine, obtained from chloroform fraction showed weaker in vitro activity and was ineffective in infected hamsters. The lead potential of this plant need further investigations. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
43. Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity
- Author
-
Kumar P, Shivam P, Mandal S, Prasanna P, Kumar S, Prasad SR, Kumar A, Das P, Ali V, Singh SK, and Mandal D
- Subjects
gold nanoparticle ,Amphotericin B ,antileishmanial ,macrophage uptake ,ergosterol ,immunostimulator ,Medicine (General) ,R5-920 - Abstract
Prakash Kumar,1 Pushkar Shivam,*,2 Saptarshi Mandal,*,3 Pragya Prasanna,1 Saurabh Kumar,1 Surendra Rajit Prasad,1 Ashish Kumar,4 Prolay Das,3 Vahab Ali,5 Shubhankar Kumar Singh,2 Debabrata Mandal11Department of Biotechnology, National Institute of Pharmaceutical Education and Research (NIPER) – Hajipur, Vaishali, India; 2Department of Microbiology, Rajendra Memorial Research Institute of Medical Sciences, Patna, India; 3Department of Chemistry, Indian Institute of Technology Patna, Patna, India; 4Department of Molecular Biology, Rajendra Memorial Research Institute of Medical Sciences, Patna, India; 5Department of Biochemistry, Rajendra Memorial Research Institute of Medical Sciences, Patna, India*These authors contributed equally to this workBackground: Amphotericin B (AmB) as a liposomal formulation of AmBisome is the first line of treatment for the disease, visceral leishmaniasis, caused by the parasite Leishmania donovani. However, nephrotoxicity is very common due to poor water solubility and aggregation of AmB. This study aimed to develop a water-soluble covalent conjugate of gold nanoparticle (GNP) with AmB for improved antileishmanial efficacy and reduced cytotoxicity.Methods: Citrate-reduced GNPs (∼39 nm) were functionalized with lipoic acid (LA), and the product GNP-LA (GL ∼46 nm) was covalently conjugated with AmB using carboxyl-to-amine coupling chemistry to produce GNP-LA-AmB (GL-AmB ∼48 nm). The nanoparticles were characterized by dynamic light scattering, transmission electron microscopy (TEM), and spectroscopic (ultraviolet–visible and infrared) methods. Experiments on AmB uptake of macrophages, ergosterol depletion of drug-treated parasites, cytokine ELISA, fluorescence anisotropy, flow cytometry, and gene expression studies established efficacy of GL-AmB over standard AmB.Results: Infrared spectroscopy confirmed the presence of a covalent amide bond in the conjugate. TEM images showed uniform size with smooth surfaces of GL-AmB nanoparticles. Efficiency of AmB conjugation was ∼78%. Incubation in serum for 72 h showed
- Published
- 2019
44. THE USE OF CYMBOPOGON CITRATUS (LEMONGRASS) EXTRACTS AS ANTILEISHMANIAL ACTIVITY.
- Author
-
Hassan, Husain F. and Taha, Sahar A.
- Subjects
LEMONGRASS ,LEISHMANIASIS treatment ,PROMASTIGOTE ,EXTRACTS -- Therapeutic use ,PLANT extracts - Abstract
The results of the current study indicated the apparent inhibitory effect of the aqueous and alcoholic extracts of Cymbopogon citratus on the growth of L. tropica and L. donovani promastigotes. The inhibitory concentration (IC50), which cause the loss of 50% of the promastigotes of L. tropica and L. donovani at the logarithmic growth phase 96 hours was shown to be 0.008 and 0.016 mg/cm3 respectively, whereas the IC50 of alcoholic extract was 0.007 mg/cm3 in both parasite forms. The results revealed decrease in total protein amount, total nucleic acid amount, RNA, and DNA concentrations, upon treating the leishmanial promastigotes with C. citratus extracts. High-pressure liquid chromatography (HPLC) analysis of the plant extracts proved to contain such phenolic active compounds which in turn may responsible for the antileishmanial activity. [ABSTRACT FROM AUTHOR]
- Published
- 2020
45. Anti-infective Activity of Bignonia Binata Leaves.
- Author
-
Mahmoud, Basma Khalaf, Samy, Mamdouh Nabil, Elsayed Hameda, Ashraf Nageeb, Desoukey, Samar Yehia, and Kamel, Mohamed Salah
- Subjects
METHICILLIN resistance ,CRYPTOCOCCUS neoformans ,ETHYL acetate ,PSEUDOMONAS aeruginosa ,CANDIDA albicans - Abstract
Objective: Evaluation of the antitrypanosmal, antileishmanial, antimicrobial and antimalarial activities of the total ethanol extract and different fractions of Bignonia binata leaves. Method: The antitrypanosomal activity was evaluated in vitro on blood stage forms of Trypanosomabrucei and the antileishmanial activity was tested against Leishmaniadonovani. The antimicrobial effect was performed against Candida albicans ATCC 90028, Cryptococcus neoformans ATCC 90113 and Aspergillusfumigatus ATCC 90906,Staphylococcus aureus ATCC 43300 (MRS), Escherichia coli ATCC 35218, Pseudomonas aeruginosa ATCC 27853 and Mycobacterium intracellulare ATCC 23068. While, the antimalarial activity was examined onchloroquine-sensitive (D6, Sierra Leone) and the chloroquine-resistant (W
2 ) strains of Plasmodium falciparum protozoan. Results: The ethyl acetate fraction exhibited 90% inhibition against Trypanosomabrucei, with IC50 value of 16.59 µg/mL. While, the aqueous fraction showed mild antimicrobial activity with inhibition 32% aginst Pseudomonas aerogenosa and 27% against methicillin resistance Staphylococcus aureus (MRS). On the other hand, all tested fractions showed no antimalarial activity at the tested concentration. Conclusion: The present study revealed the antitrypanosomal potency of B. binata leaves [ABSTRACT FROM AUTHOR]- Published
- 2020
46. In vitro antileishmanial activity of methanolic extracts for some selected medicinal plants.
- Author
-
Gomaa Darwish, Ahmed, Samy, Mamdouh, Sugimoto, Sachiko, Matsunami, Katsuyoshi, and Otsuka, Hideaki
- Subjects
MILK thistle ,MEDICINAL plants ,CULTIVATED plants ,AMPHOTERICIN B ,LEISHMANIA major ,PLANT extracts - Abstract
Objective: The aim of this study is to evaluate the antileishmanial activity of selected medicinal plants; ten well-known medicinal plants cultivated and growing under African environmental conditions were studied. Materials and Methods: The methanolic extracts of these plants were screened for their antileishmanial activity against Leishmania major using 3-(4.5-dimethylthiazol-2yl)-2.5-diphenyltetrazolium bromide assay. Results: The methanol extract of Colchicum autumnale and Alpinia officinarum showed potent antileishmanial activity at inhibition% value of 98.29% ± 0.75% and 97.25 ± 1.63%, respectively, while Silybum marianum exhibited inhibition% value of 90.97% ± 1.13%, compared with the standard amphotericin B (89.31% ± 2.08%). Conclusion: Considering these results, medicinal plants from African environment could constitute a developer source for antileishmanial compounds. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
47. Polarity directed optimization of phytochemical and in vitro biological potential of an indigenous folklore: Quercus dilatata Lindl. ex Royle.
- Author
-
Ahmed, Madiha, Fatima, Humaira, Qasim, Muhammad, Gul, Bilquees, and Ihsan-ul-Haq
- Subjects
MEDICINAL plants ,RESEARCH funding ,TRADITIONAL medicine ,PHYTOCHEMICALS ,PLANT extracts ,PLANT anatomy ,DATA analysis software ,DESCRIPTIVE statistics ,IN vitro studies - Abstract
Background: Plants have served either as a natural templates for the development of new chemicals or a phytomedicine since antiquity. Therefore, the present study was aimed to appraise the polarity directed antioxidant, cytotoxic, protein kinase inhibitory, antileishmanial and glucose modulatory attributes of a Himalayan medicinal plant- Quercus dilatata. Methods: Total phenolic and flavonoid contents were determined colorimetrically and various polyphenols were identified by RP-HPLC analysis. Brine shrimp lethality, SRB and MTT assays were employed to test cytotoxicity against Artemia salina and human cancer cell lines respectively. Antileishmanial activity was determined using standard MTT protocol. Glucose modulation was assessed by α-amylase inhibition assay while disc diffusion assay was used to establish protein kinase inhibitory and antifungal spectrum. Results: Among 14 extracts of aerial parts, distilled water-acetone extract demonstrated maximum extract recovery (10.52% w/w), phenolic content (21.37 ± 0.21 µg GAE/mg dry weight (DW)), total antioxidant capacity (4.81 ± 0.98 µg AAE/mg DW) and reducing power potential (20.03 ± 2.4 µg/mg DW). On the other hand, Distilled water extract proficiently extracted flavonoid content (4.78 ± 0.51 µg QE/mg DW). RP-HPLC analysis revealed the presence of significant amounts of phenolic metabolites (0.049 to 15.336 µg/mg extract) including, pyrocatechol, gallic acid, catechin, chlorogenic acid, p-coumaric acid, ferulic acid and quercetin. Highest free radical scavenging capacity was found in Methanol-Ethyl acetate extract (IC
50 8.1 ± 0.5 µg/ml). In the brine shrimp toxicity assay, most of the tested extracts (57%) showed high cytotoxicity. Among these, Chloroform-Methanol extract had highest cytotoxicity against THP-1 cell line (IC50 3.88 ± 0.53 µg/ml). About 50% of the extracts were found to be moderately antiproliferative against Hep G2 cell line. Methanol extract exhibited considerable protein kinase inhibitory activity against Streptomyces 85E strain (28 ± 0.35 mm bald phenotype at 100 µg/disc; MIC = 12.5 µg/disc) while, Chloroform extract displayed maximum antidiabetic activity (α-amylase inhibition of 21.61 ± 1.53% at 200 µg/ml concentration). The highest antileishmanial potential was found in Ethyl acetate-Acetone extract (12.91 ± 0.02% at 100 µg/ml concentration), while, Q. dilatata extracts also showed a moderate antifungal activity. Conclusion: This study proposes that multiple-solvent system is a crucial variable to elucidate pharmacological potential of Q. dilatata and the results of the present findings prospects its potential as a resource for the discovery of novel anticancer, antidiabetic, antileishmanial and antioxidant agents. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
48. Evaluation of antimycobacterial, leishmanicidal and antibacterial activity of three medicinal orchids of Arunachal Pradesh, India.
- Author
-
Bhatnagar, Manisha, Sarkar, Nandan, Gandharv, Nigam, Apang, Ona, Singh, Sarman, and Ghosal, Sabari
- Abstract
Background: The ethnic population of Arunachal Pradesh uses a number of orchids as such, or in decoction for various ailments. Three untapped orchids namely, Rhynchostylis retusa, Tropidia curculioides and Satyrium nepalense, traditionally used in tuberculosis, asthma and cold stage of malaria in folk medicine, were selected for the present study. Methods: Dried material of each plant was divided into three parts. Solvent extraction and fractionation afforded altogether 30 extracts and fractions, which were evaluated against Mycobacterium tuberculosis (H37Rv and MDR strain) for antimycobacterial activity; promastigotes and amastigotes of Leishmania donovani for leishmanicidal activity and two gram positive and three gram negative clinical isolates for antibacterial activity. Results: The most significant antimycobacterial activity was observed with n-hexane fraction of the flower of Satyrium nepalense with MIC of 15.7 μg/mL. The most promising leishmanicidal activity was observed with diethyl ether fraction of the roots of Rhynchostylis retusa with IC
50 values of 56.04 and 18.4 μg/mL against promastigotes and intracellular amastigotes respectively. Evaluation of antibacterial activity identified S. nepalense flower n-hexane and R. retusa roots diethyl ether as potential fractions with MIC values of ≤100 μg/mL against selected clinical isolates. Conclusions: This is the first report of the plants possessing antimycobacterial and leishmanicidal activity. The investigation resulted in identification of S. nepalense as the most promising plant, which possessed all three activities in significant proportion. This laboratory outcome could be translated to marketable pharmaceutical products and also to produce maximum benefits to the local of nearby area. Antimycobacterial and leishmanicidal activity of medicinal orchids. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
49. In Vitro Assessment of Plants Growing in Cuba Belonging to Solanaceae Family Against Leishmania amazonensis.
- Author
-
Monzote, Lianet, Jiménez, Jenny, Cuesta ‐ Rubio, Osmany, Márquez, Ingrid, Gutiérrez, Yamile, Rocha, Cláudia Quintino, Marchi, Mary, Setzer, William N., and Vilegas, Wagner
- Abstract
In this study, an in vitro antileishmanial assessment of plant extracts from 12 genera and 46 species growing in Cuba belonging to Solanaceae family was performed. A total of 226 extracts were screened against promastigotes of Leishmania amazonensis, and cytotoxicity of active extracts [median inhibitory concentration (IC50 ) promastigotes <100 µg/mL] was determined on peritoneal macrophage from BALB/c mice. Extracts that showed selective index >5 were then assayed against intracellular amastigote. Metabolomics analysis of promissory extracts was performed using chemical profile obtained by ultra performance liquid chromatography. Only 11 extracts (4.9%) from nine plants were selected as potentially actives: Brunfelsia cestroides A. Rich, Capsicum annuum L., Capsicum chinense Jacq., Cestrum nocturnum L., Nicotiana plumbaginifolia Viv., Solanum havanense Jacq., Solanum myriacanthum Dunal, Solanum nudum Dunal and Solanum seaforthianum And., with IC50 < 50 µg/mL and selectivity index >5. Metabolomics analysis demonstrated significant differences in the chemical profiles with an average of 42.8 (range 31-88) compounds from m/z 104 to 1477, which demonstrated the complex mixture of compounds. In addition, no common markers among active extracts were identified. The results demonstrate the importance of the Solanaceae family to search new antileishmanial agents, particularly in unexplored species of this family. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
50. Ursolic Acid, a Natural Pentacylcic Triterpene from Ochrosia elliptica and Its Role in The Management of Certain Neglected Tropical Diseases.
- Author
-
Labib, Rola M., Ebada, Sherif S., Youssef, Fadia S., Ashour, Mohamed L., and Ross, Samir A.
- Subjects
URSOLIC acid ,TRITERPENES ,TROPICAL medicine ,LEISHMANIASIS ,TRYPANOSOMIASIS - Abstract
Background: Leishmaniasis and African trypanosomiasis are recognized as the leading causes of mortality and morbidity with the greatest prevalence in the developing countries. They affect more than one billion of the poorest people on the globe. Objective: To find a cheap, affordable, safe, and efficacious antileshmanial and antitrypanosomal natural drug and to elucidate its probable mode of action. Materials and Methods: Phytochemical investigation of the non-polar fraction of the methanol extract of leaves of Ochrosia elliptica Labill. (Apocyanaceae) resulted in the isolation of ursolic acid, which was unambiguously determined based on HR-ESI-FTMS, extensive 1D and 2D NMR spectroscopy. It was further tested for its cytotoxicity, antimicrobial, antimalarial, antileishmanial, and trypanocidal potency. in-silico molecular modeling studies were conducted on six vital parasitic enzymes including farnesyl diphosphate synthase, N-myristoyl transferase, pteridine reductase 1, trypanothione reductase, methionyl-tRNA synthetase, and inosine-adenosine-guanosine nucleoside hydrolase to discover its potential mode of action as antitrypanosomal and antileishmanial agent. Results: Ursolic acid displayed considerable antitrypanosomal and antileishmanial activities with IC
50 values ranging between 1.53 and 8.79 μg/mL. It showed superior antitrypanosomal activity as compared to the standard drug difluoromethylornithine (DFMO), with higher binding affinities towards trypanothione reductase and pteridine reductase 1. It displayed free binding energy of -30.73 and -50.08 kcal/mole towards the previously mentioned enzymes, respectively. In addition, ursolic acid exhibited considerable affinities to farnesyl diphosphate synthase, N-myristoyl transferase and methionyl-tRNA synthetase with free binding energies ranging from -42.54 to -63.93 kcal/mole. Conclusion: Ursolic acid offers a safe, effective and cheap antitrypanosomal and antileishmanial candidate acting on several key parasitic enzymes. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.